352 related articles for article (PubMed ID: 33919253)
1. Analysis of Astroglial Secretomic Profile in the Mecp2-Deficient Male Mouse Model of Rett Syndrome.
Ehinger Y; Matagne V; Cunin V; Borloz E; Seve M; Bourgoin-Voillard S; Borges-Correia A; Villard L; Roux JC
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919253
[TBL] [Abstract][Full Text] [Related]
2. Astrocyte Transcriptome from the Mecp2(308)-Truncated Mouse Model of Rett Syndrome.
Delépine C; Nectoux J; Letourneur F; Baud V; Chelly J; Billuart P; Bienvenu T
Neuromolecular Med; 2015 Dec; 17(4):353-63. PubMed ID: 26208914
[TBL] [Abstract][Full Text] [Related]
3. Alterations of gene expression and glutamate clearance in astrocytes derived from an MeCP2-null mouse model of Rett syndrome.
Okabe Y; Takahashi T; Mitsumasu C; Kosai K; Tanaka E; Matsuishi T
PLoS One; 2012; 7(4):e35354. PubMed ID: 22532851
[TBL] [Abstract][Full Text] [Related]
4. An Astrocytic Influence on Impaired Tonic Inhibition in Hippocampal CA1 Pyramidal Neurons in a Mouse Model of Rett Syndrome.
Dong Q; Kim J; Nguyen L; Bu Q; Chang Q
J Neurosci; 2020 Aug; 40(32):6250-6261. PubMed ID: 32616668
[TBL] [Abstract][Full Text] [Related]
5. Correcting deregulated Fxyd1 expression rescues deficits in neuronal arborization and potassium homeostasis in MeCP2 deficient male mice.
Matagne V; Wondolowski J; Frerking M; Shahidullah M; Delamere NA; Sandau US; Budden S; Ojeda SR
Brain Res; 2018 Oct; 1697():45-52. PubMed ID: 29902467
[TBL] [Abstract][Full Text] [Related]
6. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
[TBL] [Abstract][Full Text] [Related]
7. MeCP2 Deficiency Leads to Loss of Glial Kir4.1.
Kahanovitch U; Cuddapah VA; Pacheco NL; Holt LM; Mulkey DK; Percy AK; Olsen ML
eNeuro; 2018; 5(1):. PubMed ID: 29464197
[TBL] [Abstract][Full Text] [Related]
8. Differential brain region-specific expression of MeCP2 and BDNF in Rett Syndrome patients: a distinct grey-white matter variation.
Pejhan S; Siu VM; Ang LC; Del Bigio MR; Rastegar M
Neuropathol Appl Neurobiol; 2020 Dec; 46(7):735-750. PubMed ID: 32246495
[TBL] [Abstract][Full Text] [Related]
9. Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions.
Maezawa I; Swanberg S; Harvey D; LaSalle JM; Jin LW
J Neurosci; 2009 Apr; 29(16):5051-61. PubMed ID: 19386901
[TBL] [Abstract][Full Text] [Related]
10. Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology.
Ballas N; Lioy DT; Grunseich C; Mandel G
Nat Neurosci; 2009 Mar; 12(3):311-7. PubMed ID: 19234456
[TBL] [Abstract][Full Text] [Related]
11. A codon-optimized Mecp2 transgene corrects breathing deficits and improves survival in a mouse model of Rett syndrome.
Matagne V; Ehinger Y; Saidi L; Borges-Correia A; Barkats M; Bartoli M; Villard L; Roux JC
Neurobiol Dis; 2017 Mar; 99():1-11. PubMed ID: 27974239
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D modulates cortical transcriptome and behavioral phenotypes in an Mecp2 heterozygous Rett syndrome mouse model.
Ribeiro MC; MacDonald JL
Neurobiol Dis; 2022 Apr; 165():105636. PubMed ID: 35091041
[TBL] [Abstract][Full Text] [Related]
13. RNA sequencing and proteomics approaches reveal novel deficits in the cortex of
Pacheco NL; Heaven MR; Holt LM; Crossman DK; Boggio KJ; Shaffer SA; Flint DL; Olsen ML
Mol Autism; 2017; 8():56. PubMed ID: 29090078
[TBL] [Abstract][Full Text] [Related]
14. Neuronal morphology in MeCP2 mouse models is intrinsically variable and depends on age, cell type, and Mecp2 mutation.
Wang IT; Reyes AR; Zhou Z
Neurobiol Dis; 2013 Oct; 58():3-12. PubMed ID: 23659895
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of the Rett syndrome experimental model mecp2
Cortelazzo A; Pietri T; De Felice C; Leoncini S; Guerranti R; Signorini C; Timperio AM; Zolla L; Ciccoli L; Hayek J
J Proteomics; 2017 Feb; 154():128-133. PubMed ID: 28062374
[TBL] [Abstract][Full Text] [Related]
16. Disruption of MeCP2 attenuates circadian rhythm in CRISPR/Cas9-based Rett syndrome model mouse.
Tsuchiya Y; Minami Y; Umemura Y; Watanabe H; Ono D; Nakamura W; Takahashi T; Honma S; Kondoh G; Matsuishi T; Yagita K
Genes Cells; 2015 Dec; 20(12):992-1005. PubMed ID: 26456390
[TBL] [Abstract][Full Text] [Related]
17. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice.
Deng V; Matagne V; Banine F; Frerking M; Ohliger P; Budden S; Pevsner J; Dissen GA; Sherman LS; Ojeda SR
Hum Mol Genet; 2007 Mar; 16(6):640-50. PubMed ID: 17309881
[TBL] [Abstract][Full Text] [Related]
18. A role for glia in the progression of Rett's syndrome.
Lioy DT; Garg SK; Monaghan CE; Raber J; Foust KD; Kaspar BK; Hirrlinger PG; Kirchhoff F; Bissonnette JM; Ballas N; Mandel G
Nature; 2011 Jun; 475(7357):497-500. PubMed ID: 21716289
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome.
Peddada S; Yasui DH; LaSalle JM
Hum Mol Genet; 2006 Jun; 15(12):2003-14. PubMed ID: 16682435
[TBL] [Abstract][Full Text] [Related]
20. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
